Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density

Henry G. Bone, Michael R. McClung, Christian Roux, Robert R. Recker, John A. Eisman, Nadia Verbruggen, Carolyn M. Hustad, Carolyn DaSilva, Arthur C. Santora, B. Avery Ince

Journal of Bone and Mineral Research, 2009

Bone Health and Osteoporosis Foundation, Université Paris Cité, Délégation Paris 5, Assistance Publique – Hôpitaux de Paris, Hôpital Cochin, Creighton University, St Vincent's Hospital, UNSW Sydney, Garvan Institute of Medical Research, MSD (Belgium), Merck & Co., Inc., Rahway, NJ, USA (United States)

Publisher Website

Abstract

This research paper explore the methodology and findings associated with Journal of Bone and Mineral Research. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

330

Citations

View on Google Scholar

Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density

Abstract

Journal Details

Join JournalsHub

Welcome Back